NSC |
Compound |
Enrichment |
Correlation |
NSC 314622 |
Indenoisoquinoline derivative |
0.00140570135773563 |
0.10737742 |
NSC 673803 |
9-Acridinamine, N-[3-[bis(2-hydroxyethyl)amino]propyl]- 7-methoxy-3-nitro- |
0.00140570135773563 |
0.5924049 |
NSC 700913 |
Null |
0.00140570135773563 |
0.6395192 |
NSC 714187 |
3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate |
0.00140570135773563 |
0.63959226 |
NSC 715067 |
Null |
0.00140570135773563 |
0.33250475 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.00159809164939554 |
0.53756079 |
NSC 617076 |
Free base of NSC 610966 |
0.00163780067775766 |
0.2842577 |
NSC 753393 |
3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine |
0.00163780067775768 |
0.034769906 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00165587325865807 |
0.51269356 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.00165587325865807 |
-0.04666573 |